Detalhe da pesquisa
1.
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
Prostate
; 82(12): 1202-1209, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35652618
2.
Differential impact of tumor suppressor gene (TP53, PTEN, RB1) alterations and treatment outcomes in metastatic, hormone-sensitive prostate cancer.
Prostate Cancer Prostatic Dis
; 25(3): 479-483, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294873
3.
Update in the management of patients with hormone-refractory prostate cancer.
Curr Opin Urol
; 15(3): 157-62, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15815191